Biotechnology in the Development of Gene-Silencing Therapies
PDF

Keywords

Gene-Silencing
RNA Interference
CRISPR/Cas9
Antisense Oligonucleotides
Biotechnology
Genetic Diseases
Therapeutic Applications

Abstract

Gene-silencing therapies, particularly RNA interference (RNAi) and CRISPR/Cas-based approaches, represent a promising class of therapeutic strategies aimed at modulating gene expression for the treatment of genetic diseases. Biotechnology has played a crucial role in the development of these therapies by advancing the understanding of molecular mechanisms of gene regulation, as well as improving delivery systems and safety profiles. This article explores the biotechnological innovations driving the development of gene-silencing therapies, including RNAi, CRISPR/Cas9, and antisense oligonucleotides, as well as their applications in treating genetic disorders. We also discuss the challenges in clinical implementation, regulatory considerations, and future prospects for gene-silencing therapies.

PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Olivia Harrison, Marcus Lee (Author)

Downloads

Download data is not yet available.